Answers are grounded in this paper and cite their sources.
Background: Imaging workup preceding stereotactic brain biopsy differs among institutions.The novel coronavirus disease-2019 (COVID-19) pandemic has prompted reallocation of scarce medical resources and reduction of unnecessary procedures.The relevant costs and value to the health system of multiple magnetic resonance imaging (MRI) scans during this workup remain poorly defined.In the current review, we specifically delineate and compare the relevant costs and value to the health system of multiple MRI scans during workup for stereotactic brain biopsy.Methods: A generalized total cost equation was formulated and used to analyze differential cost drivers across different patient scenarios from diagnosis to surgery.Results: Each additional MRI scan performed between diagnostic MRI and stereotactic brain biopsy contributes $306 for Medicare patients versus $870-$990 for patients with private insurance.The main driver for imaging costs before stereotactic brain biopsy is the number of MRI scans performed between diagnosis and surgery.Imaging costs vary significantly among insurance types. Conclusion:There is little to no clinical value of repeating additional MRI scans if outside institution MRI scans are highquality and can be sourced to the intraoperative neuronavigation system.Cost and waste reduction is achieved through reducing the number of MRI scans by using high-quality outside institution MRI scans, minimizing the interval between scanning and surgery, avoiding dedicated MRI scans with skin fiducials for neuronavigation, and not requiring another diagnostic MRI scan from within the treating institution.
No takes yet. Share an insight, caveat, or question.
Y et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: